These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 9535594)
1. Circumvention of multidrug resistance in genitourinary tumors. van Brussel JP; Mickisch GH Int J Urol; 1998 Jan; 5(1):1-15. PubMed ID: 9535594 [TBL] [Abstract][Full Text] [Related]
2. Role of multidrug resistance in tumors of the genitourinary tract. Theyer G; Hamilton G Urology; 1994 Dec; 44(6):942-50. PubMed ID: 7985331 [No Abstract] [Full Text] [Related]
4. Molecular analysis of mechanisms regulating drug sensitivity and the development of new chemotherapy strategies for genitourinary carcinomas. Naito S; Koga H; Yokomizo A; Sakamoto N; Kotoh S; Nakashima M; Kiue A; Kuwano M World J Surg; 2000 Oct; 24(10):1183-6. PubMed ID: 11071457 [TBL] [Abstract][Full Text] [Related]
5. A review of therapeutic strategies for phase I-II trials in genitourinary cancer. Friedman MA Recent Results Cancer Res; 1980; 70():203-10. PubMed ID: 7188814 [No Abstract] [Full Text] [Related]
7. Chemotherapy of genitourinary malignancies. Gordon RL Semin Drug Treat; 1973; 3(1):69-72. PubMed ID: 4123696 [No Abstract] [Full Text] [Related]
8. Genitourinary malignancies. Smith MR; Kantoff P Cancer Chemother Biol Response Modif; 1999; 18():394-417. PubMed ID: 10800495 [No Abstract] [Full Text] [Related]
9. Mechanisms of drug resistance in chemotherapy for urogenital carcinoma. Naito S; Yokomizo A; Koga H Int J Urol; 1999 Sep; 6(9):427-39. PubMed ID: 10510888 [TBL] [Abstract][Full Text] [Related]
10. Treatment of genitourinary tumours with cis-dichlorodiammineplatinum(II): experience in 250 patients. Merrin CE Cancer Treat Rep; 1979; 63(9-10):1579-84. PubMed ID: 574057 [No Abstract] [Full Text] [Related]
13. [Guideline for proper use of antineoplastic agents. Urologic cancer]. Akaza H; Miyanaga N Gan To Kagaku Ryoho; 2002 Jun; 29(6):1055-64. PubMed ID: 12109446 [No Abstract] [Full Text] [Related]
14. Heat shock proteins: their role in urological tumors. Lebret T; Watson RW; Fitzpatrick JM J Urol; 2003 Jan; 169(1):338-46. PubMed ID: 12478186 [TBL] [Abstract][Full Text] [Related]
15. Circadian chemotherapy for gynecological and genitourinary cancers. Kobayashi M; Wood PA; Hrushesky WJ Chronobiol Int; 2002 Jan; 19(1):237-51. PubMed ID: 11962679 [TBL] [Abstract][Full Text] [Related]
16. Expression of multidrug resistance related proteins and proliferative activity is increased in advanced clinical prostate cancer. Van Brussel JP; Jan Van Steenbrugge G; Van Krimpen C; Bogdanowicz JF; Van Der Kwast TH; Schröder FH; Mickisch GH J Urol; 2001 Jan; 165(1):130-5. PubMed ID: 11125381 [TBL] [Abstract][Full Text] [Related]
17. Future directions for gemcitabine in the treatment of genitourinary cancer. Vogelzang NJ Semin Oncol; 2002 Feb; 29(1 Suppl 3):40-5. PubMed ID: 11894007 [TBL] [Abstract][Full Text] [Related]
18. The role of chemotherapy in the management of malignant urogenital neoplasms. Schnipper LE Urol Clin North Am; 1976 Jun; 3(2):423-32. PubMed ID: 960317 [No Abstract] [Full Text] [Related]